Imperva (NYSE: IMPV) is one of 197 publicly-traded companies in the “IT Services & Consulting” industry, but how does it contrast to its competitors? We will compare Imperva to similar companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, earnings, valuation and profitability.

Valuation & Earnings

This table compares Imperva and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Imperva $293.55 million -$18.92 million -21.41
Imperva Competitors $2.11 billion $365.95 million 11.99

Imperva’s competitors have higher revenue and earnings than Imperva. Imperva is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

92.7% of Imperva shares are held by institutional investors. Comparatively, 61.0% of shares of all “IT Services & Consulting” companies are held by institutional investors. 2.2% of Imperva shares are held by insiders. Comparatively, 17.0% of shares of all “IT Services & Consulting” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Imperva and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imperva -4.69% -5.00% -2.98%
Imperva Competitors -23.94% -65.30% -4.43%

Risk and Volatility

Imperva has a beta of 2.23, meaning that its stock price is 123% more volatile than the S&P 500. Comparatively, Imperva’s competitors have a beta of 1.26, meaning that their average stock price is 26% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Imperva and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imperva 0 6 12 0 2.67
Imperva Competitors 1003 5124 7742 220 2.51

Imperva presently has a consensus target price of $52.57, suggesting a potential upside of 19.20%. As a group, “IT Services & Consulting” companies have a potential upside of 2.53%. Given Imperva’s stronger consensus rating and higher possible upside, equities analysts plainly believe Imperva is more favorable than its competitors.

Summary

Imperva beats its competitors on 8 of the 12 factors compared.

About Imperva

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.